0.05Open0.05Pre Close0 Volume12 Open Interest2.50Strike Price0.00Turnover1315.13%IV78.64%PremiumJan 17, 2025Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0116Delta0.0032Gamma229.40Leverage Ratio-0.0498Theta0.0000Rho-2.65Eff Leverage0.0002Vega
Wave Life Sciences Stock Discussion
Back to 16 next week
Wave Life Sciences Announces First-Ever Therapeutic Rna Editing in Humans Achieved in Restoraation-2 Trial of Wve-006 in Alpha-1 Antitrypsin Deficiency
Wave Life Sciences Ltd: Expects to Share Multidose Data From Restoraation-2 Trial in 2025
No comment yet